CSIMarket


Pro dex Inc   (PDEX)
Other Ticker:  
 


 

Pro dex Inc

PDEX's Financial Statements and Analysis



Pro dex Inc reported in the second quarter of 2024 net earnings per share of $0.14 a decrease by -41.67 % year on year from $0.24 and an improvement compare to net loss per share of $-0.17 realized in previous quarter.


second quarter of 2024
Earnings Per Share Revenues
$ 0.14 $  13 Mill
$-0.10     -41.67 % $+1M     +11.58 %



Pro Dex Inc 's Revenue rose by 11.58 % in second quarter of 2024 (Dec 31 2023) year on year, to $13 million and advanced by 5.44 % sequentially.


Pro Dex Inc is

More on PDEX's Income Statement



Pro Dex Inc 's net income of $0.500 million in the second quarter of 2024 decreased by -43.12 % from net earnings of $0.879 million achieved in II. Quarter a year ago.

Sequentially Company turn into Profitability from net loss of $-0.615 million recorded in previous quarter.

More on PDEX's Growth

Pro Dex Inc Inventories
Inventories declined by -0.72 % to $15.03 million from II. Quarter a year ago, sequentially inventories fell by -7.61 %. In Dec 31 2023 company's net cash and cash equivalents decreased by $-1 million, capital expenditures fell by -0.50924.36%, to $-1 millions compare to same quarter a year ago

More on PDEX's Cash flow Statement


Pro dex Inc does not pay out common stock dividend.

In trailing twelve-month period Pro dex Inc earned $ 1.13 cash per share, on a free-cash flow basis 341.2 % of net earning per share.

Book value grew by 0.05 % sequentially to $8.80 per share, 2661.85% of net income per share in trailing twelve-month period were contributed to shareholder value.
Tangible Book value grew to $ 8.78 per share from $ 8.77.

Company issued 0.07 million shares or 1.84 % in Dec 31 2023.
Interest Coverage Ratio was 13.86. Debt Coverage Ratio was 0.6.

More on PDEX's Dividends

 Market Capitalization (Millions) 62
 Shares Outstanding (Millions) 4
 Total Debt (Millions $) 12
 Revenue (TTM) (Millions $) 48
 Net Income (TTM) (Millions $) 5
 Cash Flow (TTM) (Millions $) 1
 Capital Exp. (TTM) (Millions $) -1
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Employees (TTM) $ -




Pro dex Inc does not pay out common stock dividend.

In trailing twelve-month period Pro dex Inc had $ 1.13 cash flow per share, on a free-cash flow basis 341.2 % of net earning per share.

Book value grew by 0.05 % sequentially to $8.80 per share, 2661.85% of net income per share in trailing twelve-month period were contributed to shareholder value.
Tangible Book value grew to $ 8.78 per share from $ 8.77.

Company issued 0.07 million shares or 1.84 % in Dec 31 2023.
Interest Coverage Ratio was 13.86. Debt Coverage Ratio was 0.6.

More on PDEX's Balance Sheets

 Market Capitalization (Millions) 62
 Shares Outstanding (Millions) 4
 Total Debt (Millions $) 12
 Revenue (TTM) (Millions $) 48
 Net Income (TTM) (Millions $) 5
 Cash Flow (TTM) (Millions $) 1
 Capital Exp. (TTM) (Millions $) -1
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Employees (TTM) $ -
   


  News about Pro dex Inc Earnings

Pro Dex Inc Delivers Impressive Performance in Second Quarter of 2024 with Excellent Results2. Concerns Arise as Pro Dex Inc Achieves Strong Revenue Growth, but experiences a Decline in Earnings per Share3. Pro Dex Inc Outshines Competitors in Medical Equipment & Supplies Sector with Remarkable Second Quarter Performance.

Pro Dex Inc, a medical equipment and supplies company, recently reported its financial results for the second quarter of 2024. While the company saw a significant improvement in revenue, with a growth of 11.576% to $12.59 million compared to the same period last year, the earnings per share (EPS) declined by -41.67% to $0.14 per share. This reduction in EPS is a cause for concern, despite the increase in revenue.
In comparison to its sector contemporaries, Pro Dex Inc's revenue growth in the second quarter of 2024 stands out positively, as the overall growth in the Medical Equipment and Supplies sector was only 3.13% during the same period. This indicates that the company is performing well in terms of r...

Pro Dex Inc's Astounding Performance: A Remarkable Journey from July to September 2023


As I analyze the financial results of Pro Dex Inc for...

Revised Headline: Pro Dex Inc Faces Challenging Quarter Amidst Industry Downturn

Pro Dex Inc, a medical equipment and supplies company, has reported its fiscal fourth-quarter results for 2023. The company experienced a zero gain of $0.00 per share in the quarter, compared to $0.19 per share the previous year and $0.36 per share in the previous reporting period. This decline in earnings is in line with the overall slump in the Medical Equipment and Supplies industry, which recorded a revenue rise.
The company's revenue also declined in the fourth quarter, dropping by 15.664% to $10.64 million from $12.62 million in the same period the previous year. Sequentially, revenue fell by 18.656% from $13.08 million. This decrease can be attributed to the challenging market conditions and slowe...

Pro Dex Inc Soars with Impressive 41.166% Revenue Surge in Q1 2023

Investors in the stock market should approach Pro Dex Inc with caution, as the company's return on asset (ROA) in its third quarter of 2023 was below its average ROA. The 9.58% ROA is an improvement from the previous quarter, but 31 other healthcare companies had a higher ROA. While the company's overall ranking for ROA has improved, it is still lower than expectedPro Dex Inc's EPS more than doubled in the first quarter of 2023, and its revenue grew by 41.166%. The company also saw an increase in net income and profit margins. However, its operating earnings showed only a 102.25% improvement.
Investors should keep an eye on the company's next financial results report, expected in September 2023. While t...


Date modified: 2024-02-08T22:47:41+00:00





Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com